Cargando…
The Evidence for Sparsentan-Mediated Inhibition of I(Na) and I(K(erg)): Possibly Unlinked to Its Antagonism of Angiotensin II or Endothelin Type a Receptor
Sparsentan is viewed as a dual antagonist of endothelin type A (ET(A)) receptor and angiotensin II (AngII) receptor and it could be beneficial in patients with focal segmental glomerulosclerosis. Moreover, it could improve glomerular filtration rate and augment protective tissue remodeling in mouse...
Autores principales: | Chuang, Tzu-Hsien, Cho, Hsin-Yen, Wu, Sheng-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773265/ https://www.ncbi.nlm.nih.gov/pubmed/35052766 http://dx.doi.org/10.3390/biomedicines10010086 |
Ejemplares similares
-
Effective Perturbations by Phenobarbital on I(Na), I(K(erg)), I(K(M)) and I(K(DR)) during Pulse Train Stimulation in Neuroblastoma Neuro-2a Cells
por: Wu, Po-Ming, et al.
Publicado: (2022) -
Sparsentan: First Approval
por: Syed, Yahiya Y.
Publicado: (2023) -
Correction to: Sparsentan: First Approval
por: Syed, Yahiya Y.
Publicado: (2023) -
Characterization in Inhibitory Effectiveness of Carbamazepine in Voltage-Gated Na(+) and Erg-Mediated K(+) Currents in a Mouse Neural Crest-Derived (Neuro-2a) Cell Line
por: Wu, Po-Ming, et al.
Publicado: (2022) -
The Effectiveness of Isoplumbagin and Plumbagin in Regulating Amplitude, Gating Kinetics, and Voltage-Dependent Hysteresis of erg-mediated K(+) Currents
por: Chen, Linyi, et al.
Publicado: (2022)